In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- News 8 On Call - Most frequently asked questions about Tuberculosis on May 23, 2019 at 3:46 pm
NEW HAVEN, Conn. (WTNH) - Dr. Luke Davis, a clinician and researcher at Yale School of Public Health, said there are 50 to 80 TB cases a year in our state -- well below the national average. ... […]
- Possible tuberculosis exposure reported at Mar Vista Academy in South San Diego on May 22, 2019 at 1:07 pm
SAN DIEGO (CNS) - San Diego County health officials announced they are working Wednesday to notify students, faculty and staff at Mar Vista Academy who may have been exposed to tuberculosis. According ... […]
- South Bay Middle School Fears Tuberculosis Exposure: County on May 22, 2019 at 12:27 pm
Students at a South Bay school may have been exposed to tuberculosis earlier this year, county health officials said Wednesday. Mar Vista Academy in Egger Highlands had a possible tuberculosis ... […]
- Case of tuberculosis at Delta College leads to health department notice for students, staff on May 21, 2019 at 9:02 pm
FRANKENLUST TWP, MI — A student who attended winter classes at Delta College was diagnosed with tuberculosis and has prompted the college to notify some students and staff. On May 13, Central Michigan ... […]
- San Antonio researchers developing new, more promising tuberculosis vaccine on May 21, 2019 at 8:32 pm
The disease is less common in the United States than it is in much of the world, but we've seen our fair share of cases locally over the past several years. So researchers at Texas Biomed in San ... […]
- Moving tuberculosis vaccines from theory to practice on May 21, 2019 at 4:32 am
Tuberculosis (TB) vaccine research has reached a unique point in time. Breakthrough findings in both the basic immunology of Mycobacterium tuberculosis infection and the clinical development of TB ... […]
- Tuberculosis Testing Market - Analysis By Trends, Top Manufacturers, Growth, Statistics, and Forecast to 2028 on May 20, 2019 at 1:55 am
May 20, 2019 (WiredRelease via COMTEX) -- Tuberculosis (TB) is one of the leading infectious diseases in the world. Tuberculosis is caused by infection of the mycobacteria complex typically ... […]
- Confirmed case of Tuberculosis found at school in North Windham on May 16, 2019 at 1:31 pm
NORTH WINDHAM, CT (WFSB) - A case of tuberculosis was confirmed at a school in North Windham. Windham Public Schools said the case was confirmed at the Charles H. Barrows STEM Academy. A letter was ... […]
- Case of tuberculosis confirmed at North Windham magnet school on May 16, 2019 at 7:36 am
Stock image of Histopathology of tuberculosis. Stock image of Histopathology of tuberculosis. WINDHAM, Conn. (WTNH) - A case of tuberculosis has been confirmed at a North Windham school. According to ... […]
- Case of Tuberculosis at C.H. Barrows STEM Academy in North Windham on May 16, 2019 at 7:11 am
There is a case of tuberculosis in a North Windham school and school officials are reaching out to families and holding a tuberculosis clinic later this month. A message to families said the case of ... […]
via Google News and Bing News